Searched for
LUPIN USFDA WARNING
Lupin gets warning letter from USFDA for Tarapur API plantDrug firm Lupin on Thursday said it has received a warning letter from the US health regulator for its Tarapur-based manufacturing facility...29 Sep, 2022, 06.31 PM IST- Lupin gets warning letter from FDA for Tarapur facility, stock falls over 2%“We wish to inform you that the company has received a warning letter from the US FDA for the company’s Tarapur, Maharashtra facility. The ...29 Sep, 2022, 12.55 PM IST
- Pharma stock that Jhunjhunwala exited in Q2 is now buzzing. Here's what analysts sayAce investor Rakesh Jhunjhunwala probably exited this counter in the second quarter, as his name was not among the shareholders holding ove...15 Dec, 2021, 12.23 PM IST
- Lupin receives EIR from USFDA for its Goa manufacturing site, shares gainLupin said USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), which means USFDA w...14 Dec, 2021, 12.37 PM IST
- Lupin gets warning letter from USFDA for Somerset facilityThe United States Food and Drug Administration (USFDA) had inspected the company's Somerset, New Jersey, facility from September 10, 2020, ...13 Jun, 2021, 04.40 PM IST
- USFDA red flags Lupin for significant violations at MP unitThe USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.04 Oct, 2019, 05.27 PM IST
- Lupin gets warning letter from USFDA for Mandideep facilityShares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.19 Sep, 2019, 11.23 AM IST
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.25 Apr, 2019, 05.25 PM IST
- Lupin shares fall 3% as USFDA warns of regulatory actionUSFDA warned the firm that it may withhold approval of any pending applications or supplements in which this facility is listed.24 Apr, 2019, 03.43 PM IST
- Lupin gets EIR from USFDA for Pithampur facilityIn November last, Lupin had received warning letter from USFDA (US Food and Drug Administration) for its manufacturing facilities in Goa an...06 Apr, 2018, 11.42 AM IST
- USFDA issues warning letter to Lupin's Goa, Indore plantsOn Lupin's Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate i...16 Nov, 2017, 11.43 PM IST
- Lupin slumps to 4-year low as USFDA issues warning letter for Goa, Indore plantsThe warning letter was issued on Monday for Pithampur unit II of Indore and its Goa plant.07 Nov, 2017, 04.17 PM IST
- Lupin gets warning letter from USFDA for Goa, Indore unitsThe company upholds quality and compliance issues with utmost seriousness and remains fully committed to be compliant with cGMP quality sta...07 Nov, 2017, 02.19 PM IST
- With several firms getting USFDA clearances, Street to breathe easy about pharma stocksLast week, Lupin, Cadila Healthcare and Alembic Pharma received clearances from the US regulator for their key facilities.12 Jul, 2016, 03.55 AM IST
- Interaction with USFDA very positive and forthcoming: Nilesh Gupta, Lupin"I think the approvals are definitely on the uptick. Inspections are a reality of life."24 Feb, 2016, 12.25 PM IST
- USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term?Manufacturing-related indiscretions of Indian firms put a question mark on prospects for generics exports.26 May, 2013, 10.45 AM IST
- Lupin’s MP plant under USFDA scannerThe US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...14 Nov, 2008, 12.00 AM IST
Load More
